In our study, the PD-1 receptor and PD-L1 ligand overexpression on CD4+ lymphocytes was particularly pronounced in patients with iPAH and CHD-PAH, while on CD8+ lymphocytes, it was observed across all patient groups. This evidence concerns the gene CD8A and pulmonary arterial hypertension.